Archives

+

New CDPHE Guidelines For Industrial Hemp Products

July 2, 2021|Blog, News | 2 Min Read

Starting July 1st, 2021, new CDPHE testing requirements go into effect. These are positive changes that will increase safety throughout the hemp supply chain. We’ve reviewed the new guidelines and […]

Read More
+

Folium Biosciences Unveils Its Website Redesign

April 27, 2021|News | 2 Min Read

Colorado Springs, Co. – April 27, 2021 – Folium Biosciences, one of the hemp industry’s leading cannabinoid manufacturers, announces the launch of its newly redesigned website, www.foliumbiosciences.com. This responsive new […]

Read More
+

Folium Biosciences Submits Novel Food Application for CBD in the UK

March 24, 2021|Blog, Media, News | 2 Min Read

Colorado Springs, Colo. – March 15, 2021 – Folium Biosciences has submitted a novel food application to the UK Food Standards Agency (FSA) for validation of its hemp-derived, 0.0% THC […]

Read More
+

Our Guide: How a Trusted Hemp Partner Can Strengthen Your Business

December 9, 2020|Blog | 15 Min Read

Deciding which hemp cannabinoid manufacturer to partner with is one of the most significant decisions that a business owner of a hemp consumer brand will ever make. From the top […]

Read More
+

J. Randal Wexler of FutureCeuticals/Van Drunen Farms and Former Nature’s Bounty Exec Mitchell Slade Join Folium Biosciences Advisory Board

December 2, 2020|News | 4 Min Read

Colorado Springs, Colo. – November 24, 2020 – Hemp-derived non-psychoactive cannabinoid manufacturer Folium Biosciences welcomes J. Randal Wexler, Vice President and General Counsel of FutureCeuticals/Van Drunen Farms, and Nature’s Bounty Co. […]

Read More
+

One Year After Securing API License for Pharma Grade CBD, Folium Biosciences Reports Broad Global Pharmaceutical Adoption

October 16, 2020|Media, News | 2 Min Read

Folium’s CBD API is an essential ingredient in pharmaceutical formulations worldwide. Colorado Springs, Colo. – October 15, 2020 – Since securing its Active Pharmaceutical Ingredient (API) license one year ago, […]

Read More
+

Global Veteran Specialty Ingredient Sales Executive Kris High Joins Folium Biosciences as Chief Commercialization Officer

September 16, 2020|Media, News | 3 Min Read

After two decades of global sales leadership in the specialty food and ingredient sectors, Kris High has joined the executive team at hemp-derived non-psychoactive cannabinoid manufacturer Folium Biosciences as the company’s first Chief Commercialization Officer

Read More
+

Broad Spectrum Stalk CBD Oil

September 14, 2020|Blog, Media, News | 2 Min Read

Folium Biosciences Introduces Broad Spectrum Stalk CBD Oil to Meet Global Demand from Stalk-and-Seed Countries Stalk-and-Seed Formulation Secures Approval for Distribution in Japan and South Korea. Folium Biosciences introduces Broad […]

Read More
+

Tricia DiPersio, PhD, RD, Joins Folium Biosciences as EVP of Quality, Compliance & Customer Relations

September 14, 2020|Media, News | 3 Min Read

Food, beverage and supplements industry veteran Tricia DiPersio, PhD, RD, has joined the executive team at Folium Biosciences as the company’s first EVP of Quality, Compliance and Customer Relations.

Read More
+

Kandy Anand Joins Folium Biosciences Board of Directors

August 27, 2020|Media, News | 3 Min Read

Colorado Springs, Colo. – September 9, 2020 – Hemp-derived, non-psychoactive cannabinoid manufacturer Folium Biosciences welcomes Kandy Anand, former Chief Growth Officer at Molson Coors Brewing Company (NYSE: TAP), to its […]

Read More